The Use of Oral Recombinant Feline Interferon Omega in Two Cats with Type II Diabetes Mellitus and Concurrent Feline Chronic Gingivostomatitis Syndrome

    October 2013 in “ Irish Veterinary Journal ”
    Rodolfo Oliveira Leal, Solange Gil, Maria Teresa Villa de Brito, David McGahie, Maria M. R. E. Niza, Luís Tavares
    TLDR Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.
    This case study described the use of oral recombinant feline interferon-omega (rFeIFN-ω) in two cats with type II diabetes mellitus (DM) and concurrent feline chronic gingivostomatitis syndrome (FCGS). Both cats, previously treated with long-acting corticosteroids, developed DM likely due to these treatments. After switching to glargine insulin and starting daily oral rFeIFN-ω, the cats showed significant improvement in FCGS symptoms and pain relief within 60 days. This was the first report of rFeIFN-ω successfully managing FCGS in type II diabetic cats, where corticosteroids were contraindicated.
    Discuss this study in the Community →